Pricing Log in Create free account
Tuesday 3 November 2026 Export CI’s income statement to Excel — free account

Cigna Group

CI Healthcare Healthcare Plans

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.

Revenue
+6.68%
EPS
+10.2%
Free cash flow
+66.9%
Total debt
+3.61%

Quarter to June 2026, against a year earlier

295.90 2.33 −0.78%
Market cap
$78.0B
P/E
12.2×
Fwd P/E
12.0×
Dividend yield
2.09%
F-score
8/9
Altman Z
2.62
Beneish M
−2.47
Dividend safety
82/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Filings

Insider Decisions last twelve months

Sold, $m 66.84
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — 2 — 1 1 — 2 1 — —
Insider Ownership 1.03%

Capital & Financial Ratios $m

Size
Market Cap 78,000.00
Revenue ttm 282,382.00
Net income ttm 6,983.00
Free cash flow ttm 9,113.00
Net debt Q 25,580.00
Valuation
P/E 12.24
Forward P/E 12.00
Price / sales 0.28
Forward P/S Powerpack
Price / FCF 8.54
Price / book 1.81
Financial health
Current ratio Q 0.74 (below 1: weak)
Debt / equity Q 0.74
Interest coverage Q 7.52
Growth
Revenue growth Q +6.68% (above 0%: growing)
Operating income growth Q +16.05% (above 0%: growing)
EPS, this year +2.25%
EPS, next year A +9.76%
Revenue, next year A +4.56%
EPS, past 5 yrs −0.69% (below 0%: weak)
EPS, next 5 yrs A +7.57%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.4×, against a ten-year median of 0.6×; over the ten years it ranged from 0.3× in 2026 to 1.8× in 2019.
P/E against its own 10 years 19.16%
10-year low 10-year high
P/S against its own 10 years 7.86%
10-year low 10-year high
P/B against its own 10 years 41.67%
10-year low 10-year high
EV/Sales against its own 10 years 7.05%
10-year low 10-year high
EV/FCF against its own 10 years 28.12%
10-year low 10-year high

Dividends raised 5 years running

Yield
2.09%
Annual rate
6.19
Payout ratio
25.6%
Growth, 2016–25
+74.6%/yr
  1. 0.04 ’16
  2. 0.04 ’17 +0%
  3. 0.04 ’18 +0%
  4. 0.04 ’19 +0%
  5. 0.04 ’20 +0%
  6. 4.00 ’21 +9900%
  7. 4.48 ’22 +12%
  8. 4.92 ’23 +10%
  9. 5.60 ’24 +14%
  10. 6.04 ’25 +8%
  11. 6.18 ’26e +2%
paid forecast Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 7,822 7,550 7,676 6,298
Receivables 22,557 28,605 32,871 34,782
Inventory — — — —
Other — — — —
30,379 36,155 40,547 41,080
2023 2024 2025 Q'26
Payables 28,368 37,759 40,992 36,634
ST’ Debt 2,775 3,035 592 2,792
Other 5,514 5,388 5,710 6,689
46,612 55,569 56,342 55,562

Compound Annual Growth %

10y 5y 3y
Sales 21.92% 11.38% 15.05%
Cash Flow 12.59% (1.49%) 3.51%
Earnings 11.02% (6.77%) (3.86%)
Book Value 13.27% (3.61%) (2.14%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 7.58 Actual 7.78

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 7.70 7.83 Beat by 0.13
Q4 FY25 7.87 8.08 Beat by 0.21
Q1 FY26 7.62 7.79 Beat by 0.17
Q2 FY26 7.58 7.78 Beat by 0.20
Q3 FY26 7.46 — Reports 5 November 2026

EPS $

Mar Jun Sep Dec Year
’26 6.26 6.29 — — —
’25 4.85 5.71 6.98 4.64 22.18
’24 (0.97) 5.45 2.63 5.13 12.12
’23 4.24 4.92 4.74 3.49 17.39
’22 3.68 4.90 8.97 3.83 21.30
’21 3.30 4.25 4.80 3.39 15.73
’20 3.15 4.73 3.78 11.45 22.96
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 68,494 71,668 — — —
’25 65,502 67,178 69,748 72,472 274,900
’24 57,255 60,523 63,694 65,649 247,121
’23 46,517 48,586 49,048 51,114 195,265
’22 44,006 45,478 45,281 45,753 180,518
’21 40,971 43,131 44,288 45,679 174,069
’20 38,469 39,265 40,955 41,712 160,401
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 1,131 (421) — — —
’25 1,920 (1,886) 3,418 6,149 9,601
’24 4,840 265 46 5,212 10,363
’23 5,028 2,492 2,826 1,467 11,813
’22 2,030 1,244 3,283 2,099 8,656
’21 1,093 (296) 2,119 4,275 7,191
’20 1,887 3,274 895 4,294 10,350
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 864 (718) — — —
’25 1,593 (2,171) 3,140 5,827 8,389
’24 4,540 (105) (353) 4,875 8,957
’23 4,620 2,095 2,423 1,102 10,240
’22 1,742 920 2,945 1,754 7,361
’21 851 (554) 1,769 3,971 6,037
’20 1,620 3,018 643 3,975 9,256
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 39,838 41,806 48,650 153,566 160,401 174,069 180,518 195,265 247,121 274,900 282,382 +23.9% 287,448 299,163 315,514 +4.7%
Gross margin, % 38.90 39.57 43.42 79.93 79.61 80.72 82.17 81.42 84.36 87.50 88.51 +48.6 pt
EBT 2,979 3,606 3,581 6,570 10,868 6,790 8,397 5,513 5,269 7,781 8,639 +11.3%
EBT margin, % 7.48 8.63 7.36 4.28 6.78 3.90 4.65 2.82 2.13 2.83 3.06 (4.6) pt
Net income 1,843 2,232 2,646 5,120 8,489 5,420 6,782 5,372 3,778 6,288 6,983 +14.6%
Per share, $
Per share, $ Revenue 156.01 166.63 197.24 408.51 439.48 515.05 583.17 664.41 881.65 1,030.58 1,073.75 +23.3%
Earnings 7.19 8.77 10.54 13.44 22.96 15.73 21.30 17.39 12.12 22.18 24.17 +13.3%
Cash flow 15.77 16.29 15.28 25.23 28.36 21.28 27.96 40.20 36.97 35.99 39.08 +9.6%
Capex (1.81) (1.88) (2.14) (2.79) (3.00) (3.41) (4.18) (5.35) (5.02) (4.54) (4.43) +10.8%
Free cash flow 13.96 14.41 13.14 22.44 25.36 17.86 23.78 34.84 31.96 31.45 34.65 +9.4%
Book value 53.76 54.65 166.37 120.62 137.89 139.45 144.37 157.35 147.14 156.98 163.16 +12.6%
Shares, m 255 251 247 376 365 338 310 294 280 267 265 +0.5%
Valuation, ×
Valuation, × P/E 18.85 23.20 17.75 15.23 9.01 14.59 15.04 17.83 22.56 12.41 12.24 16.6
P/S 0.87 1.22 0.96 0.50 0.47 0.45 0.55 0.47 0.31 0.27 0.28 0.6
P/B 2.52 3.71 1.14 1.70 1.51 1.65 2.23 1.97 1.88 1.75 1.81 2.0
EV/Sales 0.92 1.27 1.76 0.71 0.62 0.61 0.69 0.59 0.41 0.35 0.37 0.8
EV/FCF 10.24 14.74 26.36 13.00 10.67 17.59 16.94 11.16 11.37 11.59 11.35 14.4
Cash, $m
Cash, $m Operating cash flow 4,026 4,086 3,770 9,485 10,350 7,191 8,656 11,813 10,363 9,601 10,277 +10.1%
Capex (461) (471) (528) (1,050) (1,094) (1,154) (1,295) (1,573) (1,406) (1,212) (1,164) +11.3%
Free cash flow 3,565 3,615 3,242 8,435 9,256 6,037 7,361 10,240 8,957 8,389 9,113 +10.0%
Balance, $m
Balance, $m Working capital (20,139) (19,649) (12,060) (12,891) (8,449) (12,027) (12,667) (16,233) (19,414) (15,795) (14,482) (2.7%)
Net debt 1,847 2,467 38,623 32,788 22,737 28,589 25,169 23,108 24,422 23,787 25,580 +32.8%
Shareholders’ equity 13,727 13,711 41,035 45,344 50,328 47,130 44,688 46,244 41,243 41,874 42,910 +13.2%
Returns, %
Returns, % ROA 3.21 3.69 2.45 3.30 5.44 3.46 4.49 3.48 2.23 3.80 4.16 +0.6 pt
ROIC 12.39 15.23 3.26 6.46 6.97 6.55 7.56 7.69 8.96 8.76 9.09 (3.6) pt
ROE 14.49 16.31 9.63 11.82 17.68 11.02 14.60 11.36 7.85 14.33 15.40 (0.2) pt
People
People Employees 41,000 46,000 73,800 73,700 73,700 73,700 71,300 72,500 73,500 67,700 — +5.7%
Revenue/emp, $m 0.97 0.91 0.66 2.08 2.18 2.36 2.53 2.69 3.36 4.06 — +17.2%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Cigna Group vs peers in Healthcare Plans (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
UNH UnitedHealth Group Incorporated $359.4B 22.9× 21.1× −0.41% (below 0%: shrinking) +76.06% (above 0%: growing) −15.65% (below 0%: shrinking) 100.00% 5.82% Compare
CVS CVS Health Corporation $113.2B 23.2× 13.1× +7.26% (above 0%: growing) +187.65% (above 0%: growing) +338.29% (above 0%: growing) 44.52% 4.43% Compare
ELV Elevance Health, Inc. $89.4B 17.7× 18.7× +1.42% (above 0%: growing) +17.86% (above 0%: growing) +29.03% (above 0%: growing) 15.57% 4.18% Compare
CI Cigna Group $78.0B 12.2× 12.0× +6.68% (above 0%: growing) +10.16% (above 0%: growing) +66.93% (above 0%: growing) 88.24% 3.73%
HUM Humana Inc. $49.3B 38.4× 56.8× +26.18% (above 0%: growing) +27.88% (above 0%: growing) +58.51% (above 0%: growing) 13.45% 3.33% Compare
CNC Centene Corporation $32.9B 22.4× 17.4× +1.93% (above 0%: growing) n/m −437.38% (below 0%: shrinking) 6.37% (0.61%) Compare
MOH Molina Healthcare, Inc $10.9B — (loss-making) 59.6× −3.44% (below 0%: shrinking) −51.66% (below 0%: shrinking) −20.25% (below 0%: shrinking) 12.30% 0.96% Compare
OSCR Oscar Health, Inc. $9.6B 18.2× 15.8× +70.40% (above 0%: growing) n/m +316.29% (above 0%: growing) 22.25% 7.96% Compare
CLOV Clover Health Investments, Corp. $2.3B — (loss-making) 80.8× +55.60% (above 0%: growing) n/m +406.43% (above 0%: growing) 20.59% 3.77% Compare
Median of peers $41.1B 22.6× 19.9× +4.60% +27.88% +43.77% 18.08% 3.97%

All 12 Healthcare Plans stocks →

Cigna Group (CI) Latest News

29 Oct

Impact 3 · · Zacks

27 Oct

Impact 4 · · NYSE
Impact 3 · · Zacks

26 Oct

Impact 3 · · NYSE

23 Oct

Impact 3 · · Trefis

20 Oct

Impact 3 · · Zacks

19 Oct

Impact 3 · · Trefis
Impact 3 · · StockStory

16 Oct

Impact 3 · · Trefis

15 Oct

Impact 3 · · Simply Wall St.

14 Oct

Impact 3 · · Insider Monkey

13 Oct

Impact 4 · · Barchart

6 Oct

Impact 4 · · PR Newswire

1 Oct

Impact 3 · · MT Newswires

30 Sep

Impact 4 · · Simply Wall St.
Impact 4 · · MarketBeat
Impact 4 · · Simply Wall St.
Impact 4 · · PR Newswire
Impact 3 · · Simply Wall St.

29 Sep

Impact 3 · · Trefis

24 Sep

Impact 3 · · StockStory

23 Sep

Impact 3 · · Exec Edge

22 Sep

Impact 3 · · Trefis

18 Sep

Impact 4 ·

16 Sep

Impact 3 · · Trefis

15 Sep

Impact 3 ·

9 Sep

Impact 3 ·

6 Sep

Impact 4 ·

2 Sep

Impact 4 ·

27 Aug

Impact 3 ·

CI metrics, ten years each

stockrow.com/CI · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com